GlassScriptPhysician profile
Kendra Gamble-Webb
NPI 1770517674
$1,222.60
in general payments reported to CMS, 2019-2025
20 companies · $285 in 2025
The $285 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2020: $116 · 2021: $79.95 · 2022: $149 · 2023: $408 · 2024: $74.88 · 2025: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $768.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $768.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $203.09 | 2019-2022 | |
| Abbvie INC. | $163.68 | 2020-2025 | |
| Astellas Pharma US INC | $146.49 | 2023-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $99.73 | 2019-2025 | |
| Biogen, INC. | $93.91 | 2025 | Zurzuvae |
| Novo Nordisk INC | $92.22 | 2019-2025 | Wegovy |
| Mayne Pharma Commercial LLC | $78.27 | 2023 | |
| Organon LLC | $71.75 | 2023-2024 | Nexplanon |
| Myriad Women'S Health, INC. | $60.93 | 2023 | |
| Millicent US INC | $40.35 | 2025 | Intrarosa, Femlyv |
| Pacira Pharmaceuticals Incorporated | $31.08 | 2019 | |
| Lilly USA, LLC | $18.97 | 2025 | Zepbound |
| Davol INC. | $17.88 | 2023 | Arista Ah Flexitip |
| Pfizer INC. | $17.77 | 2024 | |
| Avanos Medical | $17.36 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $17.21 | 2023 | Tisseel |
| Merck Sharp & Dohme LLC | $14.73 | 2019 | |
| Hologic Sales and Service, LLC | $14.62 | 2024 | Acessa Provu System |
| Lsi Solutions INC | $13.93 | 2024 | Fornisee |
| Meditrina | $8.63 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kendra Gamble-Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.